NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIBIB E-150-2016-1-JP-04 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS JP National Stage 2020-519137 Issued
NIAID E-279-2016-1-FR-07 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE FR EP 17784795.1 Issued
NIAID E-279-2016-1-DE-06 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE DE EP 17784795.1 Issued
NIAID E-279-2016-1-IE-09 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE IE EP 17784795.1 Issued
NIAID E-279-2016-1-BE-04 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE BE EP 17784795.1 Issued
NIAID E-279-2016-1-EP-02 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE EP National Stage 17784795.1 Issued
NIAID E-279-2016-1-GB-08 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE GB EP 17784795.1 Issued
NIAID E-279-2016-1-CH-05 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE CH EP 17784795.1 Issued
NIAID E-007-2015-0-CH-20 CD47-targeted Therapies For The Treatment Of Infectious Disease CH EP 17194591.8 Issued
NIAID E-007-2015-0-TR-34 CD47-targeted Therapies For The Treatment Of Infectious Disease TR EP 17194591.8 Issued
NIAID E-007-2015-0-GB-26 CD47-targeted Therapies For The Treatment Of Infectious Disease GB EP 17194591.8 Issued
NIAID E-007-2015-0-IE-28 CD47-targeted Therapies For The Treatment Of Infectious Disease IE EP 17194591.8 Issued
NIAID E-007-2015-0-IT-29 CD47-targeted Therapies For The Treatment Of Infectious Disease IT EP 17194591.8 Issued
NIAID E-007-2015-0-FI-24 CD47-targeted Therapies For The Treatment Of Infectious Disease FI EP 17194591.8 Issued
NIAID E-007-2015-0-FR-25 CD47-targeted Therapies For The Treatment Of Infectious Disease FR EP 17194591.8 Issued
NIAID E-007-2015-0-DE-21 CD47-targeted Therapies For The Treatment Of Infectious Disease DE EP 17194591.8 Issued
NIAID E-007-2015-0-NL-31 CD47-targeted Therapies For The Treatment Of Infectious Disease NL EP 17194591.8 Issued
NIAID E-007-2015-0-LU-30 CD47-targeted Therapies For The Treatment Of Infectious Disease LU EP 17194591.8 Issued
NIAID E-007-2015-0-EP-14 CD47-targeted Therapies For The Treatment Of Infectious Disease EP DIV 17194591.8 Issued
NIAID E-007-2015-0-HR-27 CD47-targeted Therapies For The Treatment Of Infectious Disease HR EP 17194591.8 Issued
NIAID E-007-2015-0-DK-22 CD47-targeted Therapies For The Treatment Of Infectious Disease DK EP 17194591.8 Issued
NIAID E-007-2015-0-SE-33 CD47-targeted Therapies For The Treatment Of Infectious Disease SE EP 17194591.8 Issued
NIAID E-007-2015-0-NO-32 CD47-targeted Therapies For The Treatment Of Infectious Disease NO EP 17194591.8 Issued
NIAID E-007-2015-0-ES-23 CD47-targeted Therapies For The Treatment Of Infectious Disease ES EP 17194591.8 Issued
NIAID E-007-2015-0-BE-19 CD47-targeted Therapies For The Treatment Of Infectious Disease BE EP 17194591.8 Issued
NIAID E-007-2015-0-AT-18 CD47-targeted Therapies For The Treatment Of Infectious Disease AT EP 17194591.8 Issued
NIAID E-145-2011-0-US-12 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 15/723,677 10265313 Issued PDF
NIBIB E-150-2016-1-PCT-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS PCT PCT COMB PCT/US2017/054863 Expired
NIAID E-279-2016-1-PCT-01 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE PCT PCT COMB PCT/US2017/054959 Expired
NIAID E-279-2016-1-EP-10 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE EP DIV 22150234.7 Pending
NIBIB E-150-2016-1-SG-05 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS SG National Stage 11202002882V Pending
NCI E-115-2015-0-US-03 HYPOXIA INDUCIBLE FACTOR 1 (HIF-1) INHIBITORS US National Stage 15/563,851 10246463 Issued PDF
NLM E-107-2010-2-US-16 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/722,202 Abandoned
NLM E-107-2010-2-US-17 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/722,183 Abandoned
NIAID E-233-2017-0-US-01 ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US 62/567,079 Abandoned
NHLBI E-222-2022-1-US-01 Catheters and Manipulators with Deflectable Ends US 62/567,203 Expired
NCI E-173-2015-0-FR-06 Module For Freezing And Storage Of Frozen Tissue FR EP 17785103.7 Issued
NCI E-173-2015-0-DE-05 Module For Freezing And Storage Of Frozen Tissue DE EP 17785103.7 Issued
NCI E-173-2015-0-GB-07 Module For Freezing And Storage Of Frozen Tissue GB EP 17785103.7 Issued
NCI E-173-2015-0-EP-03 Module For Freezing And Storage Of Frozen Tissue EP National Stage 17785103.7 Issued
NCI E-173-2015-0-PCT-02 Module For Freezing And Storage Of Frozen Tissue PCT PCT PCT/US2017/054531 Expired
NHLBI E-207-2016-0-PCT-02 METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS PCT PCT PCT/US2017/054351 Expired
NHGRI E-090-2015-0-US-04 TAGGED FORM OF MUT ENZYME, GENETIC CONSTRUCTS INCORPORATING IT, AND ITS USE IN GENE THEREAPY US National Stage 15/563,379 Abandoned
NCI E-173-2015-0-FR-01 Module For Freezing And Storage Of Frozen Tissue FR EP 22169969.7 Pending
NCI E-173-2015-0-DE-01 Module For Freezing And Storage Of Frozen Tissue DE EP 22169969.7 Pending
NCI E-173-2015-0-EP-08 Module For Freezing And Storage Of Frozen Tissue EP DIV 22169969.7 Pending
NCI E-173-2015-0-GB-01 Module For Freezing And Storage Of Frozen Tissue GB EP 22169969.7 Pending
NCI E-237-2017-0-US-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 US 62/565,383 Abandoned
NCI E-237-2017-1-US-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION US 62/565,464 Abandoned
NHLBI E-196-2017-0-US-01 POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS US 62/565,552 Abandoned